CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05654779 · TERMINATED
Trial details
- NCT number
- NCT05654779
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2023-09-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.